Zobrazeno 1 - 10
of 97
pro vyhledávání: '"N, Dalla Venezia"'
Autor:
Gan, Yu1,2 (AUTHOR), Hao, Qian1,2 (AUTHOR), Han, Tao3 (AUTHOR), Tong, Jing1,2 (AUTHOR), Yan, Qingya3 (AUTHOR), Zhong, Hongguang4,5 (AUTHOR), Gao, Bo6 (AUTHOR), Li, Yanan6 (AUTHOR), Xuan, Zhisheng6 (AUTHOR), Li, Pengfei7 (AUTHOR), Yao, Litong8 (AUTHOR), Xu, Yingying8 (AUTHOR), Jiang, Yi‐Zhou2,9 (AUTHOR), Shao, Zhi‐Ming2,9 (AUTHOR), Deng, Jun4,5 (AUTHOR) dengjun19871106@ncu.edu.cn, Chen, Jiaxiang10 (AUTHOR) chenjiaxiang@ncu.edu.cn, Zhou, Xiang1,2,9,11 (AUTHOR) xiangzhou@fudan.edu.cn
Publikováno v:
Advanced Science. 12/18/2024, Vol. 11 Issue 47, p1-18. 18p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N Dalla Venezia, Jean Delaunay, A Forissier, J Besalduch, M Aymerich, Nicole Alloisio, JL Vives Corrons, L Denoroy, I. Besson
Publikováno v:
Blood. 82:1661-1665
We present two Spanish children with hereditary elliptopoikilocytosis. The mother displayed a symptomless elliptocytosis. Spectrin maps showed the alpha I/50–46b abnormality in the mother and in the children. The change was more conspicuous in the
Autor:
P Texier, JP Cartron, K Andrabi, Ajay Rana, Athar H. Chishti, Nicole Alloisio, N Dalla Venezia, Jean Delaunay, F Gilsanz
Publikováno v:
Blood. 82:1323-1327
Human erythrocyte p55 is a peripheral membrane protein that contains three distinct domains in its primary structure: an N-terminal domain, an SH3 motif, and a C-terminal guanylate kinase domain. We used naturally mutated red blood cells (RBCs) with
Publikováno v:
Journal of Clinical Investigation. 90:1713-1717
We studied a 43 yr-old Spanish patient with homozygous 4.1(-) hereditary elliptocytosis. Any form of protein 4.1 was missing in the red cells. Spectrin and actin were slightly, yet significantly, diminished. Alterations appeared at the level of prote
Publikováno v:
Biochemical and biophysical research communications. 378(3)
Germ-line alterations in BRCA1 are associated with an increased susceptibility to breast and ovarian cancer. The BRCA1 protein has been implicated in multiple cellular functions. We have recently demonstrated that BRCA1 reduces acetyl-CoA-carboxylase
Publikováno v:
European Journal of Cancer Supplements. 8:181-182
Publikováno v:
International journal of cancer. 88(4)
BRCA1 mutations are involved in breast and ovarian cancer predisposition in humans. The biological functions of the murine BRCA1 gene have been extensively studied but little is known about murine BRCA1 proteins. To better characterize these proteins
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 1999, 18 (27), pp.4039-4043. ⟨10.1038/sj.onc.1202780⟩
Oncogene, 1999, 18 (27), pp.4039-4043. ⟨10.1038/sj.onc.1202780⟩
Oncogene, Nature Publishing Group, 1999, 18 (27), pp.4039-4043. 〈10.1038/sj.onc.1202780〉
Oncogene, Nature Publishing Group, 1999, 18 (27), pp.4039-4043. ⟨10.1038/sj.onc.1202780⟩
Oncogene, 1999, 18 (27), pp.4039-4043. ⟨10.1038/sj.onc.1202780⟩
Oncogene, Nature Publishing Group, 1999, 18 (27), pp.4039-4043. 〈10.1038/sj.onc.1202780〉
International audience; Germ-line alterations of BRCA1 are associated with elevated risk of breast cancer. Evidence for the involvement of Brca1 in cellular differentiation and morphogenesis has been obtained in mouse models during embryogenesis. Alt
Autor:
Faouzi Baklouti, Bernard Noël, Bozon M, Philippe Maillet, Madeleine Morinière, N Dalla Venezia, F Lorenzo, J Delaunay
Publikováno v:
Human mutation. 14(2)
Protein 4.1 pre-mRNA splicing is regulated in tissue- and development-specific manners. Exon 16, which encodes the N-terminal region of the spectrin/actin-binding domain, is one of the alternatively spliced sequence motifs. It is present in late diff